Abstract
Microglia are myeloid cells of the CNS that participate both in normal CNS function and in disease. We investigated the molecular signature of microglia and identified 239 genes and 8 microRNAs that were uniquely or highly expressed in microglia versus myeloid and other immune cells. Of the 239 genes, 106 were enriched in microglia as compared with astrocytes, oligodendrocytes and neurons. This microglia signature was not observed in microglial lines or in monocytes recruited to the CNS, and was also observed in human microglia. We found that TGF-β was required for the in vitro development of microglia that express the microglial molecular signature characteristic of adult microglia and that microglia were absent in the CNS of TGF-β1âdeficient mice. Our results identify a unique microglial signature that is dependent on TGF-β signaling and provide insights into microglial biology and the possibility of targeting microglia for the treatment of CNS disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Accession codes
Change history
19 December 2013
In the version of this article initially published, the x-axis labels for the sets of graphs in Figure 2f corresponding to astrocyte, oligodendrocyte and neuron molecules consisted of six items, even though there were only five bars. âRed pulp macrophagesâ was included in error. Also, the Cleveland Clinic affiliation gave the section as the Department of Immunology; the correct affiliation is Neuroinflammation Research Center. The errors have been corrected in the HTML and PDF versions of the article.
References
Prinz, M., Priller, J., Sisodia, S.S. & Ransohoff, R.M. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat. Neurosci. 14, 1227â1235 (2011).
Ransohoff, R.M. & Cardona, A.E. The myeloid cells of the central nervous system parenchyma. Nature 468, 253â262 (2010).
Saijo, K. & Glass, C.K. Microglial cell origin and phenotypes in health and disease. Nat. Rev. Immunol. 11, 775â787 (2011).
Ginhoux, F. et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 330, 841â845 (2010).
Schulz, C. et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science 336, 86â90 (2012).
Kierdorf, K. et al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nat. Neurosci. 16, 273â280 (2013).
Greter, M. et al. Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia. Immunity 37, 1050â1060 (2012).
Ajami, B., Bennett, J.L., Krieger, C., McNagny, K.M. & Rossi, F.M. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool. Nat. Neurosci. 14, 1142â1149 (2011).
Saederup, N. et al. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice. PLoS ONE 5, e13693 (2010).
King, I.L., Dickendesher, T.L. & Segal, B.M. Circulating Ly-6C+ myeloid precursors migrate to the CNS and play a pathogenic role during autoimmune demyelinating disease. Blood 113, 3190â3197 (2009).
Dimitrijevic, O.B., Stamatovic, S.M., Keep, R.F. & Andjelkovic, A.V. Absence of the chemokine receptor CCR2 protects against cerebral ischemia/reperfusion injury in mice. Stroke 38, 1345â1353 (2007).
Butovsky, O. et al. Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS. J. Clin. Invest. 122, 3063â3087 (2012).
Geissmann, F., Jung, S. & Littman, D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71â82 [pii] (2003).
Gautier, E.L. et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 13, 1118â1128 (2012).
Rothlin, C.V., Ghosh, S., Zuniga, E.I., Oldstone, M.B. & Lemke, G. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131, 1124â1136 (2007).
Hashimoto, D. et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38, 792â804 (2013).
Yona, S. et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. Immunity 38, 79â91 (2013).
Cahoy, J.D. et al. A transcriptome database for astrocytes, neurons, and oligodendrocytes: a new resource for understanding brain development and function. J. Neurosci. 28, 264â278 (2008).
Scott, E.W. et al. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 6, 437â447 (1997).
Beers, D.R. et al. Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 103, 16021â16026 (2006).
Haynes, S.E. et al. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci. 9, 1512â1519 (2006).
Cardona, A.E., Huang, D., Sasse, M.E. & Ransohoff, R.M. Isolation of murine microglial cells for RNA analysis or flow cytometry. Nat. Protoc. 1, 1947â1951 (2006).
Jung, S. et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol. Cell Biol. 20, 4106â4114 (2000).
Beutner, C., Roy, K., Linnartz, B., Napoli, I. & Neumann, H. Generation of microglial cells from mouse embryonic stem cells. Nat. Protoc. 5, 1481â1494 (2010).
Abutbul, S. et al. TGF-beta signaling through SMAD2/3 induces the quiescent microglial phenotype within the CNS environment. Glia 60, 1160â1171 (2012).
Schilling, T., Nitsch, R., Heinemann, U., Haas, D. & Eder, C. Astrocyte-released cytokines induce ramification and outward K+ channel expression in microglia via distinct signaling pathways. Eur. J. Neurosci. 14, 463â473 (2001).
Durafourt, B.A. et al. Comparison of polarization properties of human adult microglia and blood-derived macrophages. Glia 60, 717â727 (2012).
Butovsky, O. et al. Induction and blockage of oligodendrogenesis by differently activated microglia in an animal model of multiple sclerosis. J. Clin. Invest. 116, 905â915 (2006).
Kulkarni, A.B. et al. Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA 90, 770â774 (1993).
Shull, M.M. et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359, 693â699 (1992).
Gorelik, L. & Flavell, R.A. Transforming growth factor-beta in T-cell biology. Nat. Rev. Immunol. 2, 46â53 (2002).
Carrier, Y., Yuan, J., Kuchroo, V.K. & Weiner, H.L. Th3 cells in peripheral tolerance. II. TGF-betaâtransgenic Th3 cells rescue IL-2âdeficient mice from autoimmunity. J. Immunol. 178, 172â178 (2007).
Koeglsperger, T. et al. Impaired glutamate recycling and GluN2B-mediated neuronal calcium overload in mice lacking TGF-beta1 in the CNS. Glia 61, 985â1002 (2013).
Perry, V.H., Hume, D.A. & Gordon, S. Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 15, 313â326 (1985).
Borkowski, T.A., Letterio, J.J., Farr, A.G. & Udey, M.C. A role for endogenous transforming growth factor beta 1 in Langerhans cell biology: the skin of transforming growth factor beta 1 null mice is devoid of epidermal Langerhans cells. J. Exp. Med. 184, 2417â2422 (1996).
Kaplan, D.H. et al. Autocrine/paracrine TGFbeta1 is required for the development of epidermal Langerhans cells. J. Exp. Med. 204, 2545â2552 (2007).
Alliot, F., Godin, I. & Pessac, B. Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res. Dev. Brain Res. 117, 145â152 (1999).
Herbomel, P., Thisse, B. & Thisse, C. Zebrafish early macrophages colonize cephalic mesenchyme and developing brain, retina, and epidermis through a M-CSF receptorâdependent invasive process. Dev. Biol. 238, 274â288 (2001).
Chan, W.Y., Kohsaka, S. & Rezaie, P. The origin and cell lineage of microglia: new concepts. Brain Res. Rev. 53, 344â354 (2007).
Ginhoux, F., Lim, S., Hoeffel, G., Low, D. & Huber, T. Origin and differentiation of microglia. Front. Cell. Neurosci. 7, 45 (2013).
Paolicelli, R.C. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 333, 1456â1458 (2011).
Flanders, K.C. et al. Localization and actions of transforming growth factor-beta s in the embryonic nervous system. Development 113, 183â191 (1991).
Hamby, M.E., Hewett, J.A. & Hewett, S.J. Smad3-dependent signaling underlies the TGF-beta1âmediated enhancement in astrocytic iNOS expression. Glia 58, 1282â1291 (2010).
Henrich-Noack, P., Prehn, J.H. & Krieglstein, J. TGF-beta 1 protects hippocampal neurons against degeneration caused by transient global ischemia. Dose-response relationship and potential neuroprotective mechanisms. Stroke 27, 1609â1614, discussion 1615 (1996).
Wiessner, C. et al. Expression of transforming growth factor-beta 1 and interleukin-1 beta mRNA in rat brain following transient forebrain ischemia. Acta Neuropathol. 86, 439â446 (1993).
Flanders, K.C., Ren, R.F. & Lippa, C.F. Transforming growth factor-betas in neurodegenerative disease. Prog. Neurobiol. 54, 71â85 (1998).
Brionne, T.C., Tesseur, I., Masliah, E. & Wyss-Coray, T. Loss of TGF-beta 1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron 40, 1133â1145 (2003).
Wake, H., Moorhouse, A.J., Jinno, S., Kohsaka, S. & Nabekura, J. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J. Neurosci. 29, 3974â3980 (2009).
Saijo, K. et al. A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death. Cell 137, 47â59 (2009).
Peri, F. & Nusslein-Volhard, C. Live imaging of neuronal degradation by microglia reveals a role for v0-ATPase a1 in phagosomal fusion in vivo. Cell 133, 916â927 (2008).
Ginhoux, F. et al. The origin and development of nonlymphoid tissue CD103+ DCs. J. Exp. Med. 206, 3115â3130 (2009).
Gekas, C., Rhodes, K.E. & Mikkola, H.K. Isolation and visualization of mouse placental hematopoietic stem cells. Curr. Protoc. Stem Cell Biol. 2.2A, 8.1â8.14 (2008).
Ginhoux, F. et al. Blood-derived dermal langerin+ dendritic cells survey the skin in the steady state. J. Exp. Med. 204, 3133â3146 (2007).
Coquery, C.M., Loo, W., Buszko, M., Lannigan, J. & Erickson, L.D. Optimized protocol for the isolation of spleen-resident murine neutrophils. Cytometry A 81, 806â814 (2012).
Weigert, O. et al. CD4+ Foxp3+ regulatory T cells prolong drug-induced disease remission in (NZBxNZW) F1 lupus mice. Arthritis Res. Ther. 15, R35 (2013).
Mallon, B.S., Shick, H.E., Kidd, G.J. & Macklin, W.B. Proteolipid promoter activity distinguishes two populations of NG2-positive cells throughout neonatal cortical development. J. Neurosci. 22, 876â885 (2002).
Liu, L. et al. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat. Neurosci. 13, 319â326 (2010).
Huttlin, E.L. et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell 143, 1174â1189 (2010).
Ting, L., Rad, R., Gygi, S.P. & Haas, W. MS3 eliminates ratio distortion in isobaric multiplexed quantitative proteomics. Nat. Methods 8, 937â940 (2011).
Elias, J.E. & Gygi, S.P. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat. Methods 4, 207â214 (2007).
Acknowledgements
We thank D. Julius (University of California, San Francisco) for providing polyclonal antibody to P2ry12 and N. Kassam for support in antibody generation, A. Krichevsky and A. Wong Hon-Kit (Brigham and Women's Hospital, Harvard Medical School) for providing neurons, and L. Spangler for technical assistance for oligodendrocyte isolation. We thank D. Kozoriz for the FACS sorting. This work was supported by US National Institutes grant AG027437, US National Institutes Transformative Grant AG-043975, a grant from the Amyotrophic Lateral Sclerosis Association (1V78RI, ALSA 2087), a grant from Department of Defense ALS Research Program (AL120029), a Thome Foundation AMD grant, and philanthropic support. We thank Prize4Life for providing SOD1 mice.
Author information
Authors and Affiliations
Contributions
O.B. and H.L.W. conceived the study, designed the experiments and wrote the paper. O.B., A.J.L., G.G., T.K., B.D., R.C., P.M.W., C.E.D. and Z.F. performed experiments. M.P.J. and S.P.G. performed mass spectrometry experiments. C.S.M. and J.P.A. performed human microglia studies. Z.C., J.D.R., L.L. and R.M.R. performed CNS cell isolation studies. All authors discussed the results and conclusions and reviewed the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Integrated supplementary information
Supplementary Figure 1 Identification of protein signature in microglia and Ly6C monocyte subsets.
(a) Schematic representation of the workflow for TMT-based quantitative proteomic analysis of microglia and splenic Ly6C monocytes. (b) Protein expression scatter plot of microglia versus monocytes subsets. (c) Venn diagram of unique and common proteins in microglia vs. Ly6CHi and Ly6CLow monocytes. (d) Heatmap of 103 enriched microglia proteins (>5-fold).
Supplementary Figure 2 Top biological functions in microglia.
Microglia and monocyte gene signature identified by AffyExon1 arrays (see Fig. 1a) were analyzed by Ingenuity pathway analysis (IPAâ¢). Bars indicate molecules present in dataset for each function.
Supplementary Figure 3 Nervous system development and function in microglia.
The subcellular localization of top microglial functions genes from Supplementary Figure 2 (Nervous system development and function, hereditary disorders, neurological disease genes) are illustrated. For each molecule in the dataset the expression fold change as compared to monocytes, P value and normalized expression level are presented.
Supplementary Figure 4 Top microglial interactions by protein function.
Illustration of microglial PU.1 network.
Supplementary Figure 5 Canonical pathways in microglia and monocytes.
Microglial and monocytes gene signatures identified with AffyExon1 arrays were analyzed by IPA⢠for canonical pathways. Bars indicate âlog P value (ratio of molecules present in the dataset out of all the function related molecules).
Supplementary Figure 6 TGF-β pathway in microglia
For each molecule in the dataset the expression fold change as compared to monocytes, P value and normalized expression level are presented.
Supplementary Figure 7 miRNA profile in microglia vs. astrocytes, oligodendrocytes and neurons.
(a) Heatmap of biological duplicates for FCRLS+ adult microglia (n = 5 mice), Glt-EGFP+ adult astrocytes (n = 9 mice), adult oligodendrocytes (n = 5 mice) and primary postnatal hippocampal and cortical neurons. Top 25 enriched miRNAs in microglia are presented (full miRNA list, Source data â Supplementary Figure 7). Each lane represents the average expression value of two biological duplicates per cell type. (b) qPCR analysis of microglia enriched miRNAs (miR-342-3p, miR-99a and miR-125b-5p) in CNS cell type. miRNA expression level was normalized against U6 miRNA using ÎCt. Bars show mean ±SEM. Shown is one of two individual experiments.
Supplementary Figure 8 Specificity of P2ry12 and FCRLS antibodies in resident microglia.
(a) Immonohistochemical analysis of mouse spinal cord, spleen red and pulp, lung, kidney, liver and skin (ear) stained with anti-P2ry12 (microglia; red), anti-Iba-1 (myeloid cells; green) and DAPI (nucleus; blue). Representative images of 3-5 mice. (b) FACS analysis of FCRLS surface expression in splenic CX3CR1GFP/+ monocytes and CD11b/CD45+ brain microglia. (c and d) Confocal images of mouse brain stained with Iba-1 and polyclonal FCRLS antibody in (c) naïve and (d) chimeric CX3CR1GFP/+ mice. Anti-FCRLS signal co-localized with Iba-1+ microglia and does not stain recruited monocytes in the brain of CX3CR1GFP chimeric mouse transplanted with bone marrow derived cells from CX3CR1GFP/+ transgenic mice.
Supplementary Figure 9 Microglia signature during development.
(a) MG400 expression profile of microglia from mice bran at E10.5, E12.5, P3, P21, P30 and 2 months of age (full gene list, Source data â Supplementary Figure 9). Results were log-transformed, normalized (to the mean expression of zero across samples) and centered, and populations and genes were clustered by pairwise centroid linkage with the Pearson correlation. Data are pooled of 2 different experiments (n = 5-10 pooled mice per group). (b) Top microglial molecules grouped according to cell localization and function. (c) qPCR analysis of 6 selected microglia genes in MCSF+TGF-β1 cultured microglia. Gene expression level was normalized against Gapdh using ÎCt.
Supplementary Figure 10 M0, M1 and M2 microglial phenotypes as measured by MG400 chip.
(a) Heatmap of significantly affected MG400 genes in M0, M1 and M2 polarized microglia. One representative of three individual experiments is shown. (b) Top 40 affected genes in M0, M1 and M2 microglia. Bars represent fold change as compared to the other two phenotypes. (c and d) IPA⢠analysis of (c) top bio functions and (d) Top upstream regulators in M0-, M1- and M2-polarized microglia.
Supplementary Figure 11 Microglia loss in CNS-TGFβ1â/â mice.
(a) Representative FACS analysis of isolated brain- and spinal cord-derived mononuclear cells stained with CD45 and CD11b antibodies at 160d of age in IL2TGFβ1-Tg-TGF-β1+/â (n = 6) and IL2TGFβ1-Tg-TGF-β1â/â (n = 6) mice. (b and c) Increased apoptosis of CD39+CD11b+ cells in the brain of CNS-TGFβ1â/â mice. (b) Representative FACS analysis of isolated brain-derived mononuclear cells for apoptosis as measured by AnnexinV and 7AA-D in CD39+CD11b+-gated cells at 160d of age in IL2TGFβ1-Tg-TGF-β1+/â (left) and IL2TGFβ1-Tg-TGF-β1â/â (right) mice. (c) Quantitative analysis of AnnexinV+7AAD+ cell as percentage of CD39+CD11b+ cells in TGF-β1â/â, IL2TGF-β1-Tg-TGF-β1+/â and IL2TGF-β1-Tg-TGF-β1â/â mice at 20, 90 and 160 days of age. Data represent mean ±SEM (n = 3 mice per group). **P<0.01, 1-Way ANOVA followed by Dunnett's multiple-comparison post-hoc test for comparison at 20d and **P<0.01, ***P<0.001, Student's t test, 2-tailed for comparison at 90d and 160d.
Supplementary Figure 12 Macrophages, dendritic cells and Langerhans cells are not affected in peripheral organs of CNS-TGFβ1â/â mice.
(a-d) Nonlymphoid and lymphoid tissue myeloid cells isolated from IL2TGFβ1-Tg-TGF-β1+/â (left) and IL2TGFβ1-Tg-TGF-β1â/â (right) mice at 160d were analyzed by flow cytometry. FACS representative dot plots show the percentage and absolute numbers of (a) kidney, liver, lung, spleen and skin derived CD11b+F4/80+ macrophages and (b) Langerhans cell (LC) stained with MHCII+CD11b+ and Langerin+CD11b+ in the ear skin cell suspension among DAPIâCD45+ cells of IL2TGFβ1-Tg-TGF-β1+/â (n = 6) and IL2TGFβ1-Tg-TGF-β1â/â (n = 6) mice. (c) Plots show percentage of CD11c+ DCs among gated DAPIâCD3âCD19âNK1.1+ cells. (d) Dot plots show percentage of CD103+ and CD11b+ DCs among gated DAPI-CD45+CD11c+I-A+ cells. Bars represent data from 2 pooled experiments. Errors bars represent ±SEM.
Supplementary Figure 13 Loss of microglia during development in CNS-TGF-β1 deficient mice
FACS analysis of CD39 and CD11b expression among CD45+ cells in the brain during development and aging. Data represent mean ±SEM (n = 4-6 mice per group).
Supplementary Figure 14 Microglia loss in the spinal cord of CNS-TGFβ1â/â mice.
(a) Representative FACS analysis of isolated spinal cords-derived mononuclear cells stained for FCRLS, F4/80, CD39 and CD11b among hematopoietic (CD45+) cells at 20d of age in in IL2TGF-β1-Tg-TGF-β1+/â and IL2TGF-β1-Tg-TGF-β1â/â mice). Immonohistochemical analysis of mouse spinal cord axial section of lumbar level stained with (b) anti-P2ry12 (microglia) and anti-NeuN (neurons) and (c) anti-P2ry12 (microglia), Iba-1 (myeloid cells) and anti-NeuN (neurons) at 20 days of age (IL2TGF-β1-Tg-TGF-β1+/â and IL2TGF-β1-Tg-TGF-β1â/â) mice. Representative images of 3-5 mice. Scale bar represents 500μm (top panel) and 250μm (zoomed are indicated, bottom panel). (d) Quantitative analysis of NeuN+, Iba-1+ and P2ry12+/Iba-1+ cells in IL2TGF-β1-Tg-TGF-β1+/â and IL2TGF-β1-Tg-TGF-β1â/â mice at 20, 90 and 160 days of age. Data represent mean ±SEM (n = 5). **P<0.01, ***P<0.001, Student's t test, 2-tailed.
Supplementary Figure 15 TGF-β pathway and downstream microglial molecules are suppressed in CNS-TGFβ1â/â mice.
For each molecule in the dataset the expression fold change as compared to microglia from IL2TGF-β1-Tg-TGF-β1+/â mice, P value and normalized expression level are presented.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1â15 and Supplementary Tables 1â4 (PDF 11887 kb)
Supplementary Table 2
Top unique microglial genes and shared genes between microglia, neurons, astrocytes and oligodendrocytes. List of 152 identified genes which are enriched in adult microglia and not in adult astrocytes, oligodendrocytes and neurons. (XLSX 25 kb)
Rotorod performance of CNS-TGFβ1â/â mice
IL2TGFβ1-Tg-TGF-β1â/â (left) and IL2TGFβ1-Tg-TGF-β1+/â (right) mice at the age of 140 days of age. (MOV 8329 kb)
Rights and permissions
About this article
Cite this article
Butovsky, O., Jedrychowski, M., Moore, C. et al. Identification of a unique TGF-βâdependent molecular and functional signature in microglia. Nat Neurosci 17, 131â143 (2014). https://doi.org/10.1038/nn.3599
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.3599
This article is cited by
-
Border-associated macrophages in the central nervous system
Journal of Neuroinflammation (2024)
-
IKKβ deletion from CNS macrophages increases neuronal excitability and accelerates the onset of EAE, while from peripheral macrophages reduces disease severity
Journal of Neuroinflammation (2024)
-
Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimerâs disease
Journal of Neuroinflammation (2024)
-
Lifelong absence of microglia alters hippocampal glutamatergic networks but not synapse and spine density
EMBO Reports (2024)
-
Early involvement of peripherally derived monocytes in inflammation in an NMO-like mouse model
Scientific Reports (2024)